Britannia Life Sciences Inc. (CSE:BLAB)
Canada · Delayed Price · Currency is CAD 0.0650
+0.0050 (8.33%)
Oct 8, 2026, 9:04 AM EST
Britannia Life Sciences Market Cap
Britannia Life Sciences has a market cap or net worth of CAD 10.7 million as of October 9, 2026. It is the 43,201st most valuable company in the world and the 1,597th biggest in Canada. Its market cap has decreased by 30.60% in one year.
Market Cap
10.70M
Enterprise Value
-1.50M
Revenue
406.44K
Global Rank
Country Rank
#1,597 Canada
PE Ratio
0.70
ChartMarket Cap Chart
Since November 18, 2021, Britannia Life Sciences's market cap has decreased from 41.95M to 10.70M, a decrease of -74.50%. That is a compound annual growth rate of -24.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 10.70M | -26.74% |
| Dec 31, 2025 | 14.60M | 12.50% |
| Dec 19, 2024 | 12.98M | 6.67% |
| Dec 29, 2023 | 12.17M | 7.14% |
| Dec 30, 2022 | 11.36M | -60.48% |
| Dec 31, 2021 | 28.74M | -31.48% |
| Nov 18, 2021 | 41.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lobe Sciences | 20.37M |
| Alzai Health | 20.09M |
| Hemostemix | 15.86M |
| Rapid Dose Therapeutics | 13.78M |
| Rakovina Therapeutics | 10.03M |
| COSCIENS Biopharma | 9.57M |
| PreveCeutical Medical | 9.57M |
| Marvel Biosciences | 8.49M |